Bend Research Licenses Spray-dried Dispersion Tech to Lilly

This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development.

US drug-formulation development and manufacturing company Bend Research has licensed its spray-dried dispersion (SDD) technology to Eli Lilly and Co. This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development.

Lilly will also have access to Bend Research's portfolio of other drug delivery technologies.

Also, as part of an existing agreement, Bend Research will continue to provide formulation, development, analytical, engineering and manufacturing services to support Lilly’s preclinical and clinical development programs.

Rod Ray, chief executive officer of B